Organon & Co. (OGN) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free OGN Stock Alerts $20.56 -0.42 (-2.00%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Organon & Co. Short Interest DataCurrent Short Interest8,110,000 sharesPrevious Short Interest12,090,000 sharesChange Vs. Previous Month-32.92%Dollar Volume Sold Short$175.58 millionShort Interest Ratio3.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares257,170,000 sharesFloat Size256,660,000 sharesShort Percent of Float3.16%Today's Trading Volume1,447,206 sharesAverage Trading Volume2,575,655 sharesToday's Volume Vs. Average56% Short Selling Organon & Co. ? Sign up to receive the latest short interest report for Organon & Co. and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOGN Short Interest Over TimeOGN Days to Cover Over TimeOGN Percentage of Float Shorted Over Time Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here Organon & Co. Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20248,110,000 shares $175.58 million -32.9%3.2%3.8 $21.65 4/30/202412,090,000 shares $224.99 million +10.5%4.7%5.1 $18.61 4/15/202410,940,000 shares $193.75 million +0.1%4.3%4.7 $17.71 3/31/202410,930,000 shares $205.48 million +7.9%4.3%4 $18.80 3/15/202410,130,000 shares $185.18 million +4.3%4.0%3.4 $18.28 2/29/20249,710,000 shares $169.05 million -27.2%3.8%2.7 $17.41 Get the Latest News and Ratings for OGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organon & Co. and its competitors with MarketBeat's FREE daily newsletter. 2/15/202413,340,000 shares $248.39 million +8.2%5.2%3.4 $18.62 1/31/202412,330,000 shares $205.29 million -10.7%4.8%3 $16.65 1/15/202413,810,000 shares $231.32 million -27.8%5.4%3 $16.75 12/31/202319,120,000 shares $275.71 million +5.8%7.5%3.4 $14.42 12/15/202318,070,000 shares $236.36 million +25.8%7.1%3.3 $13.08 11/30/202314,370,000 shares $162.67 million -1.7%5.6%2.9 $11.32 11/15/202314,620,000 shares $169.01 million +36.3%5.7%3.2 $11.56 10/31/202310,730,000 shares $158.70 million -3.3%4.2%2.5 $14.79 10/15/202311,100,000 shares $192.25 million +10.9%4.4%3 $17.32 9/30/202310,010,000 shares $173.77 million +37.9%3.9%4.1 $17.36 9/15/20237,260,000 shares $141.86 million +4.3%2.8%3.3 $19.54 8/31/20236,960,000 shares $152.84 million -0.9%2.7%3.3 $21.96 8/15/20237,020,000 shares $163.29 million +12.9%2.8%3.3 $23.26 7/31/20236,220,000 shares $136.72 million -7.2%2.4%2.7 $21.98 7/15/20236,700,000 shares $137.48 million -8.3%2.6%3.2 $20.52 6/30/20237,310,000 shares $152.12 million +5.5%2.9%3.6 $20.81 6/15/20236,930,000 shares $144.94 million -4.4%2.7%3.5 $20.92 5/31/20237,250,000 shares $140.58 million +5.1%2.9%3.5 $19.39 5/15/20236,900,000 shares $143.80 million +11.7%2.7%3.3 $20.84 4/30/20236,180,000 shares $152.21 million -8.9%2.4%3 $24.63 4/15/20236,780,000 shares $161.36 million -1.2%2.7%3.4 $23.80 3/31/20236,860,000 shares $161.35 million +7.4%2.7%3.2 $23.52 3/15/20236,390,000 shares $137.51 million -12.2%2.5%3 $21.52 2/28/20237,280,000 shares $178.29 million +31.7%2.9%3.4 $24.49 2/15/20235,530,000 shares $161.81 million +15.9%2.2%2.7 $29.26 1/31/20234,770,000 shares $143.72 million -22.6%1.9%2.5 $30.13 1/15/20236,160,000 shares $197.49 million -14.2%2.4%3 $32.06 12/30/20227,180,000 shares $200.54 million +4.5%2.8%3.6 $27.93 12/15/20226,870,000 shares $194.28 million +16.4%2.7%3.4 $28.28 11/30/20225,900,000 shares $153.52 million +7.1%2.3%3 $26.02 11/15/20225,510,000 shares $137.09 million -3.0%2.2%2.9 $24.88 10/31/20225,680,000 shares $148.70 million -1.7%2.2%3 $26.18 10/15/20225,780,000 shares $134.73 million -4.3%2.3%3.2 $23.31 9/30/20226,040,000 shares $141.34 million +1.7%2.4%3.5 $23.40The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 9/15/20225,940,000 shares $170.78 million +12.3%2.3%3.8 $28.75 8/31/20225,290,000 shares $150.92 million -2.6%2.1%3.5 $28.53 8/15/20225,430,000 shares $168.38 million -2.9%2.1%3.7 $31.01 7/31/20225,590,000 shares $177.31 million +1.6%2.2%3.7 $31.72 7/15/20225,500,000 shares $175.84 million -4.7%2.2%3.6 $31.97 6/30/20225,770,000 shares $194.74 million -8.1%2.3%3.8 $33.75 6/15/20226,280,000 shares $210.95 million -1.3%2.5%4 $33.59 5/31/20226,360,000 shares $241.43 million -17.0%2.5%3.5 $37.96 5/15/20227,660,000 shares $267.64 million +14.7%3.0%3.7 $34.94 4/30/20226,680,000 shares $215.96 million -2.6%2.6%3.1 $32.33 4/15/20226,860,000 shares $239.41 million +16.7%2.7%3.1 $34.90 3/31/20225,880,000 shares $205.39 million -0.2%2.3%2.6 $34.93 3/15/20225,890,000 shares $190.19 million +6.9%2.3%2.6 $32.29 2/28/20225,510,000 shares $205.69 million +11.5%2.2%2.6 $37.33 2/15/20224,940,000 shares $173.99 million +14.1%2.0%2.4 $35.22 1/31/20224,330,000 shares $138.17 million +20.6%1.8%2 $31.91 1/15/20223,590,000 shares $117.97 million -5.3%1.4%1.7 $32.86 12/31/20213,790,000 shares $115.41 million -12.5%1.5%1.9 $30.45 12/15/20214,330,000 shares $127.00 million +6.9%1.7%2.1 $29.33 11/30/20214,050,000 shares $118.38 million +33.2%1.6%2.1 $29.23 11/15/20213,040,000 shares $101.48 million -25.7%1.2%1.6 $33.38 10/29/20214,090,000 shares $150.31 million -7.5%1.6%2.1 $36.75 10/15/20214,420,000 shares $154.21 million +14.5%1.7%2.2 $34.89 9/30/20213,860,000 shares $126.57 million -9.8%1.5%1.9 $32.79 9/15/20214,280,000 shares $144.32 million +4.4%1.7%1.8 $33.72 8/31/20214,100,000 shares $138.95 million -22.2%1.6%1.3 $33.89 8/13/20215,270,000 shares $180.29 million No Change2.1%1.4 $34.21 OGN Short Interest - Frequently Asked Questions What is Organon & Co.'s current short interest? Short interest is the volume of Organon & Co. shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 8,110,000 shares of OGN short. 3.16% of Organon & Co.'s shares are currently sold short. Learn More on Organon & Co.'s current short interest. What is a good short interest ratio for Organon & Co.? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGN shares currently have a short interest ratio of 4.0. Learn More on Organon & Co.'s short interest ratio. Which institutional investors are shorting Organon & Co.? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organon & Co.: Walleye Trading LLC, Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organon & Co.? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.16% of Organon & Co.'s floating shares are currently sold short. Is Organon & Co.'s short interest increasing or decreasing? Organon & Co. saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 8,110,000 shares, a decrease of 32.9% from the previous total of 12,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organon & Co.'s float size? Organon & Co. currently has issued a total of 257,170,000 shares. Some of Organon & Co.'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organon & Co. currently has a public float of 256,660,000 shares. How does Organon & Co.'s short interest compare to its competitors? 3.16% of Organon & Co.'s shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Organon & Co.: Alnylam Pharmaceuticals, Inc. (2.01%), Teva Pharmaceutical Industries Limited (1.16%), Genmab A/S (0.45%), Royalty Pharma plc (3.47%), BeiGene, Ltd. (1.75%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Sarepta Therapeutics, Inc. (6.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Organon & Co. stock? Short selling OGN is an investing strategy that aims to generate trading profit from Organon & Co. as its price is falling. OGN shares are trading down $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organon & Co.? A short squeeze for Organon & Co. occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGN, which in turn drives the price of the stock up even further. How often is Organon & Co.'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Alnylam Pharmaceuticals Short Interest Teva Pharmaceutical Industries Short Interest Genmab A/S Short Interest Royalty Pharma Short Interest BeiGene Short Interest BioMarin Pharmaceutical Short Interest Viatris Short Interest United Therapeutics Short Interest Dr. Reddy's Laboratories Short Interest Sarepta Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:OGN) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star[Urgent!] Generational Wealth GameplanCrypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeWho are Nvidia’s New Silent Partners?Weiss RatingsThe 7th Trillion Dollar Company?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.